The Securities and Exchange Commission has announced that it has resolved civil FCPA charges against the French drug company, Sanofi, and its Kazakh and Middle Eastern subsidiaries. The company will pay $25 million to settle allegations that it participated in bribery schemes to secure government tenders and increase prescriptions.
September 4, 2018
Pharmaceutical giant charged with bribery
Related by Topic
New Post
DOJ settles FCPA investigation with reinsurance brokers Tysers and H.W. Wood
November 24, 2023
News Alert
DOJ issues FCPA Opinion Procedure Release concerning stipends for foreign officials
November 12, 2023
News Alert